69 related articles for article (PubMed ID: 3201558)
1. Current strategy for donor-specific blood transfusions including a pre- and post transplant role for azathioprine.
Salvatierra O
Transplant Proc; 1988 Dec; 20(6 Suppl 8):37-41. PubMed ID: 3201558
[TBL] [Abstract][Full Text] [Related]
2. Donor-specific blood transfusions versus cyclosporine--the DST story.
Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
[TBL] [Abstract][Full Text] [Related]
3. Renal transplants from HLA-haploidentical living-related donors. The influence of donor-specific transfusions and different immunosuppressive regimens.
Leivestad T; Albrechtsen D; Flatmark A; Thorsby E
Transplantation; 1986 Jul; 42(1):35-8. PubMed ID: 3523880
[TBL] [Abstract][Full Text] [Related]
4. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions.
Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for rejection in a donor-specific transfusion plus azathioprine protocol.
Stratta RJ; Burlingham WJ; Pirsch JD; Armbrust MJ; Grailer A; Kalayoglu M; Belzer FO; Sollinger HW
Transplant Proc; 1988 Dec; 20(6):1092-5. PubMed ID: 3201555
[No Abstract] [Full Text] [Related]
6. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
[TBL] [Abstract][Full Text] [Related]
7. Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.
Aalten J; Bemelman FJ; van den Berg-Loonen EM; Claas FH; Christiaans MH; de Fijter JW; Hepkema BG; Hené RJ; van der Heide JJ; van Hooff JP; Lardy NM; Lems SP; Otten HG; Weimar W; Allebes WA; Hoitsma AJ
Nephrol Dial Transplant; 2009 Aug; 24(8):2559-66. PubMed ID: 19474284
[TBL] [Abstract][Full Text] [Related]
8. Changes in donor-specific cell-mediated lympholysis (CML) response associated with success of early steroid withdrawal in DST-azathioprine-treated renal transplant recipients.
Burlingham WJ; Grailer A; Sollinger HW
Transplant Proc; 1989 Feb; 21(1 Pt 2):1818-9. PubMed ID: 2523595
[No Abstract] [Full Text] [Related]
9. Multivariate analysis of risk factors for sensitization and early rejection episodes in a donor-specific transfusion plus azathioprine protocol.
Burlingham WJ; Stratta RJ; Mason B; Ambrust MJ; Kalayoglu M; Belzer FO; Sollinger HW
Transplantation; 1988 Feb; 45(2):342-5. PubMed ID: 3257833
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific transfusion (DST) with intermittent administration of azathioprine induces suppressor T cells and MLR-inhibiting factors without sensitization.
Haisa M; Sakagami K; Matsumoto T; Kawamura T; Uchida S; Fujiwara T; Shiozaki S; Inagaki M; Orita K
Transplant Proc; 1989 Feb; 21(1 Pt 2):1814-7. PubMed ID: 2523594
[No Abstract] [Full Text] [Related]
11. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
12. Update of the University of California at San Francisco experience with donor-specific blood transfusions.
Salvatierra O; Iwaki Y; Vincenti F; Amend W; Terasaki P; Garovoy M; Duca R; Hopper S; Feduska N
Transplant Proc; 1982 Jun; 14(2):363-6. PubMed ID: 7051480
[TBL] [Abstract][Full Text] [Related]
13. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report.
Egidi MF; Scott DH; Corry RJ
Clin Transplant; 1993 Jun; 7(3):240-4. PubMed ID: 10148843
[TBL] [Abstract][Full Text] [Related]
14. Mismatched living, related donor renal transplantation: a prospective, randomized study.
Sommer BG; Ferguson RM
Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
[TBL] [Abstract][Full Text] [Related]
15. Related donor kidney transplantation is the best form of treatment for uremia.
Groth CG; Fehrman I; Ringdén O; Lundgren G
Transplant Proc; 1987 Feb; 19(1 Pt 3):2278-9. PubMed ID: 2978893
[No Abstract] [Full Text] [Related]
16. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era.
Marti HP; Henschkowski J; Laux G; Vogt B; Seiler C; Opelz G; Frey FJ
Transpl Int; 2006 Jan; 19(1):19-26. PubMed ID: 16359373
[TBL] [Abstract][Full Text] [Related]
17. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
[No Abstract] [Full Text] [Related]
18. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
Anderson CB; Sicard GA; Etheredge EE
Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
20. The UNOS Scientific Renal Transplant Registry.
Cecka JM
Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
